Literature DB >> 7698533

Revised classification of neuroendocrine tumors of the lung, pancreas and gut.

C Capella1, P U Heitz, H Höfler, E Solcia, G Klöppel.   

Abstract

The general use of the term carcinoid for the classification of neuroendocrine tumors has become increasingly difficult during recent years. First, its definition and prognosis varies from site to site. Second, its traditional definition does not cover the whole morphological and biological spectrum of neuroendocrine tumors known today. We therefore propose new classifications of the neuroendocrine tumors of the lung, pancreas, stomach, duodenum, jejunum-ileum, appendix and colorectum. These classifications use a common framework and attempt to consider the morphological, functional and biological features of these tumors.

Entities:  

Mesh:

Year:  1994        PMID: 7698533     DOI: 10.1159/000201197

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  21 in total

Review 1.  Classic and recent special stains used in differential diagnosis of endocrine tumors.

Authors:  G Bussolati; M Volante; M Papotti
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

2.  Gastric adenocarcinoma? Looks similar but behaves differently!

Authors:  Tarun Rustagi; Mridula Rai; Todd J Alekshun
Journal:  J Gastrointest Cancer       Date:  2012-03

3.  Gastric carcinoid tumors without autoimmune gastritis in Japan: a relationship with Helicobacter pylori infection.

Authors:  Yuichi Sato; Mitsuya Iwafuchi; Jun-Ichi Ueki; Akira Yoshimura; Tsutomu Mochizuki; Hirotaka Motoyama; Kazuhito Sugimura; Terasu Honma; Rintaro Narisawa; Takafumi Ichida; Hitoshi Asakura; D H Van Thiel
Journal:  Dig Dis Sci       Date:  2002-03       Impact factor: 3.199

Review 4.  Genomics of High-Grade Neuroendocrine Neoplasms: Well-Differentiated Neuroendocrine Tumor with High-Grade Features (G3 NET) and Neuroendocrine Carcinomas (NEC) of Various Anatomic Sites.

Authors:  Silvia Uccella; Stefano La Rosa; Jasna Metovic; Deborah Marchiori; Jean-Yves Scoazec; Marco Volante; Ozgur Mete; Mauro Papotti
Journal:  Endocr Pathol       Date:  2021-01-12       Impact factor: 3.943

Review 5.  [Therapy of carcinoids of the stomach].

Authors:  H D Becker; A Gabriel
Journal:  Langenbecks Arch Chir       Date:  1996

6.  Consensus recommendations for the diagnosis and management of well-differentiated gastroenterohepatic neuroendocrine tumours: a revised statement from a Canadian National Expert Group.

Authors:  W Kocha; J Maroun; H Kennecke; C Law; P Metrakos; J F Ouellet; R Reid; C Rowsell; A Shah; S Singh; S Van Uum; R Wong
Journal:  Curr Oncol       Date:  2010-06       Impact factor: 3.677

Review 7.  Unraveling tumor grading and genomic landscape in lung neuroendocrine tumors.

Authors:  Giuseppe Pelosi; Mauro Papotti; Guido Rindi; Aldo Scarpa
Journal:  Endocr Pathol       Date:  2014-06       Impact factor: 3.943

Review 8.  Current management of gastrointestinal carcinoid tumors.

Authors:  Kenneth J Woodside; Courtney M Townsend; B Mark Evers
Journal:  J Gastrointest Surg       Date:  2004 Sep-Oct       Impact factor: 3.452

9.  Diagnostic value of (18)F-fluorodeoxyglucose positron emission tomography for pancreatic neuroendocrine tumors with reference to the World Health Organization classification.

Authors:  Toshihiko Masui; Ryuichiro Doi; Tatsuo Ito; Kazuhiro Kami; Kohei Ogawa; Daisuke Harada; Shinji Uemoto
Journal:  Oncol Lett       Date:  2010-01-01       Impact factor: 2.967

10.  Gastrointestinal carcinoid tumors: factors that predict outcome.

Authors:  Jamie J Van Gompel; Rebecca S Sippel; Tom F Warner; Herbert Chen
Journal:  World J Surg       Date:  2004-03-04       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.